XML 24 R14.htm IDEA: XBRL DOCUMENT
v3.25.2

Accrued expenses and other current liabilities | 6 Months Ended
--- | ---
Jun. 30, 2025
Accrued expenses and other current liabilities |
Accrued expenses and other current liabilities |
7 | Accrued expenses and other current liabilities
Accrued expenses and other current liabilities as of June 30, 2025 and December 31, 2024 consist of the following: ​
​ | ​ | ​ | ​ | ​
​ | ​ | June 30, | ​ | December 31,
​ |  | 2025 |  | 2024
​ | ​ | $ | ​ | $
Accrued employee compensation | ​ | 2,000 | ​ | 706
Clinical trials | ​ | 1,293 | ​ | 325
Other general accruals | ​ | 509 | ​ | 1,804
Accrued expenses and other current liabilities | ​ | 3,802 | ​ | 2,835
​

X
- Definition The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 720 -SubTopic 30 -Name Accounting Standards Codification -Section 45 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483384/720-30-45-1 + Details
Name: | us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration